These days, just about everyone is recommending a different way to lose weight. Whether it’s the latest ultra-low-fat diet, high-intensity exercise regimes like CrossFit or medications injected weekly ...

The online health platform Hers has launched a new weight loss membership for GLP-1 treatments. The membership starts at $39 for the first month and then costs $149 per month. Hers offers various ...

If you’re on a weight loss journey, you now have an arsenal of medications at your disposal. And while injectable medications have dominated the space for years, GLP-1 weight loss pills are now on the ...

The onslaught of media coverage about blockbuster weight-loss drugs, such as Ozempic and Zepbound, may make it seem as though they work magic. But some people have little success losing weight with ...

Weight loss is complex – and goes beyond counting calories, according to experts. Dr. Jason Fung, a kidney specialist and author of the recent book "The Hunger Code," said lasting weight loss requires ...

Foundayo, a new weight loss pill from Eli Lilly, is the first oral GLP-1 that doesn't require fasting. In clinical trials, people lost an average of 8-25 pounds on the drug. One man who took the pill ...

Add Yahoo as a preferred source to see more of our stories on Google. The reason some people on weight-loss jabs shed pounds more easily than others may be because of their DNA, scientists have found.

A new study suggests that simplifying your diet by eating the same meals and keeping your calorie intake consistent could help you lose more weight. Researchers found that people who followed ...

The US Food and Drug Administration on Wednesday approved the second GLP-1 pill for weight loss, adding another option to a rapidly growing arsenal of obesity therapies. The orforglipron pill, called ...

Share on Pinterest Can eating more of the same meals lead to better weight loss? Johner Images/Getty Images Despite the growing popularity of GLP-1 medications for weight loss, many people prefer to ...

The U.S. Food and Drug Administration’s approval of Eli Lilly’s once-daily pill orforglipron as a weight loss and obesity treatment this week was the fastest approval of a new medication in decades.